NCT05679843

Brief Summary

Gensini score (GS) provides valuable information on severity and prognosis of coronary artery disease (CAD). We aim to evaluate the relationship between the severity of CAD determined by the GS and short and long term of ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2023

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 24, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

January 11, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

June 7, 2023

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

June 7, 2023

Status Verified

June 1, 2023

Enrollment Period

23 days

First QC Date

December 24, 2022

Last Update Submit

June 6, 2023

Conditions

STEMI - ST Elevation Myocardial Infarction

Keywords

STEMI, Gensini,

Outcome Measures

Primary Outcomes (1)

  • Composite outcome including all cause death and re myocardial infarction

    6 years

Secondary Outcomes (1)

  • ST resolution on ECG after primary PCI

    1 hour

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with STEMI underwent primary PCI within 24 hours after first symptoms in our hospital

You may qualify if:

  • Patients with STEMI underwent primary PCI within 24 hours after first symptoms

You may not qualify if:

  • Patients with STEMI 24 hours after first symptoms Pregnant patient \<18 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Popovic B, Varlot J, Humbertjean L, Sellal JM, Pace N, Hammache N, Fay R, Eggenspieler F, Metzdorf PA, Camenzind E. Coronary Embolism Among Patients With ST-Segment-Elevation Myocardial Infarction and Atrial Fibrillation: An Underrecognized But Deadly Association. J Am Heart Assoc. 2024 May 21;13(10):e032199. doi: 10.1161/JAHA.123.032199. Epub 2024 May 14.

    PMID: 38742522DERIVED

MeSH Terms

Conditions

ST Elevation Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD,PhD

Study Record Dates

First Submitted

December 24, 2022

First Posted

January 11, 2023

Study Start

June 7, 2023

Primary Completion

June 30, 2023

Study Completion

July 1, 2023

Last Updated

June 7, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share